|
Market Closed -
Japan Exchange
10:30:00 18/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 177.00 JPY | +3.51% |
|
-25.94% | -32.70% |
| 09-09 | StemRIM Reports Earnings Results for the Full Year Ended July 31, 2026 | CI |
| 07-22 | Stemrim Announces Patent Registration in Mexico for Redasemtide as Therapeutic Agent for Cartilage Disorders | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 68.79M | - | - | - | - | - |
| 78.83B | |||||
| 60.48B | |||||
| 63.11B | - | ||||
| 46.75B | |||||
| 45.66B |
- Stock Market
- Stocks
- 4599 Stock
- Charts StemRIM
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
